KP Biosciences' Unattributed Round

KP Biosciences raised a round of funding on February 02, 2017.

KP Biosciences is a broad-spectrum antiviral company that is developing treatments for some of the world's most problematic infectious diseases, including pox viruses and herpes viruses.…

Articles about KP Biosciences' Unattributed Round: